Neuroproteomic profiling of human body fluids (Q38569255)

4 September 2017

Neuroproteomic profiling of human body fluids (English)

1 reference

4 September 2017

3

Peter Nilsson

1 reference

4 September 2017

Anna Häggmark

1

1 reference

PubMed ID

26286680

4 September 2017

Jochen M Schwenk

series ordinal

2

1 reference

4 September 2017

19 August 2015

1 reference

Proteomics - Clinical Applications

4 September 2017

1 reference

4 September 2017

10

1 reference

4 September 2017

485-502

1 reference

4 September 2017

4

1 reference

An anatomically comprehensive atlas of the adult human brain transcriptome

4 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomics. Tissue-based map of the human proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Defining the Human Brain Proteome Using Transcriptomics and Antibody-Based Profiling with a Focus on the Cerebral Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Integrated analysis of transcriptomic and proteomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

A draft map of the human proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Mass-spectrometry-based draft of the human proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Deciphering the human brain proteome: characterization of the anterior temporal lobe and corpus callosum as part of the Chromosome 15-centric Human Proteome Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Shotgun mass spectrometry analysis of the human thalamus proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic atlas of the human olfactory bulb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Shotgun proteomics in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Postmortem brain: an underutilized substrate for studying severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Postmortem changes in the level of brain proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Neuropeptides--an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Establishing the proteome of normal human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cerebrospinal fluid outflow: an evolving perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The role of APP and BACE1 trafficking in APP processing and amyloid-β generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Mild cognitive impairment: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Use of proteomic methods in the analysis of human body fluids in Alzheimer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Clinical differentiation of parkinsonian syndromes: Prognostic and therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic identification of novel proteins in cortical lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Blood-based biomarkers for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cerebrospinal Fluid Oligoclonal Bands in the Diagnosis of Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Ten years of proteomics in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

T cells become licensed in the lung to enter the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Body fluid biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Targets of the humoral autoimmune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Neurofascin as a novel target for autoantibody-mediated axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Potassium channel KIR4.1 as an immune target in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Lipid microarrays identify key mediators of autoimmune brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Autoantibody profiling in multiple sclerosis using arrays of human protein fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Bispecificity for myelin and neuronal self-antigens is a common feature of CD4 T cells in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Advances in motor neurone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The epidemiology of ALS: a conspiracy of genes, environment and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Electrodiagnostic criteria for diagnosis of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

TDP-43 plasma levels are higher in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Evidence for autoimmunity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Biomarkers for psychiatric disorders: where are we standing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Disruption of two novel genes by a translocation co-segregating with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Mechanisms of dendritic cell trafficking across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Autoimmune and inflammatory mechanisms of CNS damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Neurofilaments as biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Inflammation in neurodegenerative diseases--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The danger model in deciphering autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multiplexing approaches for autoantibody profiling in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Standardized protocols for quality control of MRM-based plasma proteomic workflows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Biological and methodical challenges of blood-based proteomics in the field of neurological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Comparative protein profiling of serum and plasma using an antibody suspension bead array approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Profiling post-centrifugation delay of serum and plasma with antibody bead arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Developments in biobanking workflow standardization providing sample integrity and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Affinity prefractionation for MS-based plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Protease bias in absolute protein quantitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Enhanced sequence coverage of proteins in human cerebrospinal fluid using multiple enzymatic digestion and linear ion trap LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Selectivity analysis of single binder assays used in plasma protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Generation of monospecific antibodies based on affinity capture of polyclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

A genome-wide association study identifies protein quantitative trait loci (pQTLs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Identification of cis-regulatory variation influencing protein abundance levels in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Females live longer than males: role of oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Contributing factors in multiple sclerosis and the female sex bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Gender differences in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The female X-inactivation mosaic in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Gender differences in Parkinson's disease: clinical characteristics and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Antibody Suspension Bead Arrays within Serum Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500065

21 January 2018

Identifiers

DOI

10.1002/PRCA.201500065

1 reference

4 September 2017

1 reference

PubMed ID

26286680